Global Clinical Trial Outsourcing and Management Market

Clinical Trial Outsourcing and Management Comprehensive Study by Services (Data Management, Site Management, Clinical Supply Management, Record Management, Others), Development (Enterprise-wide CTMS, On-Site CTMS), By Trials (Civil trials, Criminal trials, Juvenile, Traffic., Others), End User (Large Pharma-biotech Companies, CROs, Small-sized Pharma-biotech Companies, Mid-sized Pharma-biotech Companies, Others)

Clinical Trial Outsourcing and Management Market by XX Submarkets | Forecast Years 2022-2027

Summary
Market Segments
Table of Content
List of Table & Figures
Players Profiled

What is Clinical Trial Outsourcing and Management Market?

A clinical trial is a particular type of research that tests one treatment against another. It may involve either patients or people in good health, or both. The fragmented structure of the CRO industry has led to an increase in strategic alliances, acquisitions, joint-ventures and other partnership deals as companies attempt to expand their service offerings and geographical presence.

Highlights from Clinical Trial Outsourcing and Management Market Study

Attributes	Details
Study Period	2017-2027
Base Year	2021
Unit	Value (USD Million)
Key Companies Profiled	Clinipace (United States), Pfizer (United States), Novo Nordisk (Denmark), Eli Lilly (India), Syneos Health (United States), ICON (Ireland), WuXi AppTec (China), PRA Health Sciences (United States), SGS (Switzerland), Parexel International (United States) and Charles River Laboratories (United States)

The key manufacturers are targeting the innovations of the products with better quality, and also assist in providing and humanizing the after-sale service to the consumers. The key players are probable to keep a stronghold on the market over the anticipated period. The key players are accepting strategic decisions and are thinking upon mergers and acquisitions in order to maintain their presence in the market. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Clinical Trial Outsourcing and Management market throughout the forecasted period.

Clinipace (United States), Pfizer (United States), Novo Nordisk (Denmark), Eli Lilly (India), Syneos Health (United States), ICON (Ireland), WuXi AppTec (China), PRA Health Sciences (United States), SGS (Switzerland), Parexel International (United States) and Charles River Laboratories (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are IQVIA (United States), Labcorp Drug Development (United States), Syneos Health (United States) and Thermo Fisher Scientific (United States).

Clinical Trial Outsourcing and Management Market Segmentation:

Scope	Sub-Segments
Services	Data Management,Site Management,Clinical Supply Management,Record Management,Others
Development	Enterprise-wide CTMS,On-Site CTMS
By Trials	Civil trials,Criminal trials,Juvenile,Traffic.,Others
End User	Large Pharma-biotech Companies,CROs,Small-sized Pharma-biotech Companies,Mid-sized Pharma-biotech Companies,Others

On the basis of geography, the market of Clinical Trial Outsourcing and Management has been segmented into . Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:

Emerging trends in contract research industry in India and Clinical Trial Industry is Rising Outsourcing of Trial Activities

Market Growth Drivers:

Rising Prevalence of Chronic Diseases and Increase in Number of Contract Research Organization

Challenges:

Financial challenges due to financial constraints arising out of lack of funds, and inadequately trained personnel

Restraints:

Lack of Experience Regarding Regulatory Processes, Operational Expertise and Clinical CROs Focus on Clinical Trial Services such as Medical Writing, Data Analysis, Obtaining Regulatory Approvals and Regulatory Filing

Opportunities:

Increasing New Number of Investors is creating the Opportunities and Rise in R&D by Growing Pharmaceutical and Biotechnology Industries

Key Target Audience

Analysts and Strategic Business Planners, Providers of Clinical Trial Imaging, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations, Regulatory Bodies, Potential Investors and Others

Market Leaders & Development Strategies

On 13th May 2021, Virgo Investment Group LLC announced portfolio company Clinipace Incorporated a full-service Clinical Research Organization headquartered in Raleigh, North Carolina, has merged with dMed Global a full-service CRO based in Shanghai, China. The strategic merger will create a global mid-size CRO that will deliver innovative solutions to patients worldwide, and meet the needs of fast-moving biotech, pharma, and medical device companies around the world.
On 20th Jan 2022, Novo Nordisk, the Danish drug maker announced the launch of oral semaglutide in India for treatment of type 2 diabetes. "We have kept it at the (similar) price range of the injectable GLP-1, not only that we have followed price equilibrium band, which means if a person goes from 3 mg to 7 mg, the cost they pay is just 9-10% higher, and not double, as per conventional models," said Vikrant Shrotriya, corporate vice president and managing director, Novo Nordisk India.

Market Segments

Report Objectives / Segmentation Covered

By Services

Data Management
Site Management
Clinical Supply Management
Record Management
Others

By Development

Enterprise-wide CTMS
On-Site CTMS

By By Trials

Civil trials
Criminal trials
Juvenile
Traffic.
Others

By End User

Large Pharma-biotech Companies
CROs
Small-sized Pharma-biotech Companies
Mid-sized Pharma-biotech Companies
Others

By Regions

Table of Content

List of Tables & Figures

List of Tables

Table 1. Clinical Trial Outsourcing and Management: by Services(USD Million)
Table 2. Clinical Trial Outsourcing and Management: by Development(USD Million)
Table 3. Clinical Trial Outsourcing and Management: by End User(USD Million)
Table 4. Company Basic Information, Sales Area and Its Competitors
Table 5. Company Basic Information, Sales Area and Its Competitors
Table 6. Company Basic Information, Sales Area and Its Competitors
Table 7. Company Basic Information, Sales Area and Its Competitors
Table 8. Company Basic Information, Sales Area and Its Competitors
Table 9. Company Basic Information, Sales Area and Its Competitors
Table 10. Company Basic Information, Sales Area and Its Competitors
Table 11. Company Basic Information, Sales Area and Its Competitors
Table 12. Company Basic Information, Sales Area and Its Competitors
Table 13. Company Basic Information, Sales Area and Its Competitors
Table 14. Company Basic Information, Sales Area and Its Competitors
Table 15. Clinical Trial Outsourcing and Management: by Services(USD Million)
Table 16. Clinical Trial Outsourcing and Management: by Development(USD Million)
Table 17. Clinical Trial Outsourcing and Management: by End User(USD Million)
Table 18. Research Programs/Design for This Report
Table 19. Key Data Information from Secondary Sources
Table 20. Key Data Information from Primary Sources

List of Figures

Companies Mentioned

List of companies from research coverage that are profiled in the study

Clinipace (United States)
Pfizer (United States)
Novo Nordisk (Denmark)
Eli Lilly (India)
Syneos Health (United States)
ICON (Ireland)
WuXi AppTec (China)
PRA Health Sciences (United States)
SGS (Switzerland)
Parexel International (United States)
Charles River Laboratories (United States)

Additional players considered in the study are as follows:

IQVIA (United States) , Labcorp Drug Development (United States) , Syneos Health (United States) , Thermo Fisher Scientific (United States)

Select User Access Type

Single User
$ 3800
Corporate User
$ 7000

Key Highlights of Report

Sep 2022 232 Pages 69 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing

Check Discount Now

Global Clinical Trial Outsourcing and Management Market Quantitative research analysis

Global Clinical Trial Outsourcing and Management Market Qualitative Industry Analysis

DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?

"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Which factors would majorly drive the Clinical Trial Outsourcing and Management Market?

"Rising Prevalence of Chronic Diseases " is seen as one of major growth factors of Clinical Trial Outsourcing and Management Market in years to come.

Can we have customized study for Clinical Trial Outsourcing and Management Market?

The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.

Why are some known companies left out of the Clinical Trial Outsourcing and Management Market report?

The Clinical Trial Outsourcing and Management market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete of companies available in our research coverage.

Know More About Global Clinical Trial Outsourcing and Management Market Report?

Have a Query? Click Here